Clinical trial
Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia
NCT00405171 · University Hospital, Caen, Other · Completed
Key facts
| NCT number | NCT00405171 |
|---|---|
| Title | Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia |
| Official title | Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia: A Randomized Controlled Study |
| Lead sponsor | University Hospital, Caen, Other |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Hypercholesterolemia, Antiretroviral Therapy |
| Intervention type | Drug |
| Interventions | Nevirapine |
| Enrollment | 40 |
| Start date | Jun 1, 2003 |
| Completion | Feb 1, 2006 |
| First posted | Nov 29, 2006 |
| Last update posted | Oct 28, 2010 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: